Veterinary Medicines

Alpha Ject Micro 6 Emulsion for Injection for Atlantic Salmon

Authorised
  • Infectious pancreatic necrosis virus, serotype Sp, Inactivated
  • Moritella viscosa, Inactivated
  • Aeromonas salmonicida, Inactivated
  • Vibrio anguillarum, serotype O1, Inactivated
  • Vibrio anguillarum, serotype O2A, Inactivated
  • Aliivibrio salmonicida, Inactivated
Download as PDF

Product identification

Medicine name:
ALPHA JECT micro 6 emulsion for injection for Atlantic salmon
ALPHA JECT micro 6 injeksjonsvæske, emulsjon til atlantisk laks
Alpha Ject Micro 6 Emulsion for Injection for Atlantic Salmon
Active substance:
  • Infectious pancreatic necrosis virus, serotype Sp, Inactivated
  • Moritella viscosa, Inactivated
  • Aeromonas salmonicida, Inactivated
  • Vibrio anguillarum, serotype O1, Inactivated
  • Vibrio anguillarum, serotype O2A, Inactivated
  • Aliivibrio salmonicida, Inactivated
Target species:
  • Atlantic salmon
Route of administration:
  • Intraperitoneal use

Product details

Active substance and strength:
  • Infectious pancreatic necrosis virus, serotype Sp, Inactivated
    0.28
    antigen unit(s)
    /
    0.05
    millilitre(s)
  • Moritella viscosa, Inactivated
    60.00
    Relative Percentage Survival
    /
    0.05
    millilitre(s)
  • Aeromonas salmonicida, Inactivated
    70.00
    Relative Percentage Survival
    /
    0.05
    millilitre(s)
  • Vibrio anguillarum, serotype O1, Inactivated
    75.00
    Relative Percentage Survival
    /
    0.05
    millilitre(s)
  • Vibrio anguillarum, serotype O2A, Inactivated
    75.00
    Relative Percentage Survival
    /
    0.05
    millilitre(s)
  • Aliivibrio salmonicida, Inactivated
    90.00
    Relative Percentage Survival
    /
    0.05
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Atlantic salmon
      • Meat
        0
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI10AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • 250 ml bag
  • 500 ml bag

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmaq AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmaq AS
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 21714/4007
Date of authorisation status change:
Reference member state:
  • Norway
Procedure number:
  • NO/V/0008/001
Concerned member states:
  • Ireland
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/11/2021
Download

Package Leaflet

English (PDF)
Published on: 22/11/2021
Download

Labelling

English (PDF)
Published on: 22/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."